Protocols
1 protocol(s) meet the specified criteria
Drug: PEMETREXED
Protocol No.TitleStatus
CALGB30704A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib (NSC #736511, IND #74019) or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer Open (affiliates only)